MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a prevalent neurologic degenerative condition, and its pathological manifestations are mainly characterized by amyloid beta-peptide (Aβ) plaques and tau neurofibrillary tangles (Jack et al., 2018; Scheltens et al., 2021).